Shares of IDEXX Laboratories (NASDAQ:IDXX) traded 0.05 points or 0.05% higher at $89.06.The total intraday money flow for the shares came in at a disappointing $(-9.79) million. The total upticks amounted to $0.11 million and the total downticks were approximately $9.9 million, with the up/down ratio of 0.01. On a different note, the shares have seen 0.2% price change during the week.In a block trade which occurred during the day, the stock had an inflow of $0 million in upticks and an outflow of $9.81 million in downticks. The up/down ratio for the block was found to be 0. The net money flow for the block transaction was $(-9.81) million.
IDEXX Laboratories, Inc. has lost 1.37% in the last five trading days and dropped 0.76% in the last 4 weeks. IDEXX Laboratories, Inc. is up 16.18% in the last 3-month period. Year-to-Date the stock performance stands at 20.21%.
Currently the company Insiders own 2.79% of IDEXX Laboratories shares according to the proxy statements. Institutional Investors own 96.3% of IDEXX Laboratories shares. During last six month period, the net percent change held by insiders has seen a change of -4.76%. . On the companys insider trading activities, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the director of Idexx Laboratories Inc /De, End William T had sold 4,924 shares worth of $422,824 in a transaction dated May 5, 2016. In this transaction, 4,924 shares were sold at $85.87 per share.
IDEXX Laboratories (NASDAQ:IDXX) witnessed a decline in the market cap on Friday as its shares dropped 1.52% or 1.35 points. After the session commenced at $88.71, the stock reached the higher end at $89.415 while it hit a low of $87.05. With the volume soaring to 873,349 shares, the last trade was called at $87.66. The company has a 52-week high of $91.9448. The company has a market cap of $7,848 million and there are 89,531,171 shares in outstanding. The 52-week low of the share price is $61.58.
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The Company sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its segments include Companion Animal Group (CAG), Water, Livestock, Poultry and Dairy, and Other. Its Products and services include point-of-care veterinary diagnostic products; veterinary reference laboratory diagnostic and consulting services; practice management systems and services, and digital imaging systems; biological materials testing, laboratory animal diagnostic instruments and services; diagnostic, health-monitoring and food safety testing products for livestock, poultry and dairy; products that test water for microbiological contaminants, and point-of-care electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.